Author: BusinessWire

Preeminent biotechnology commercialization leader with over 33 years of industry experience, including 16 years at Genentech with a pivotal role in commercializing products across multiple therapeutic areas
GAINESVILLE, Fla.–(BUSINESS WIRE)–Cyclo Th…

OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs …

OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs …

OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched two new clinical development programs …

DUBLIN–(BUSINESS WIRE)–The “Global Drug Delivery Devices Market (2020-2025) by device type, route of administration, application, end-user, vehicle outlook, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has b…

CHENGDU, China–(BUSINESS WIRE)–Lipigon Pharmaceuticals AB (”Lipigon”), developer of therapeutics for lipid-related diseases, today announced that the company has expanded its agreement with the Shanghai STAR listed company HitGen Inc. (”HitGen”) to i…

— Presentation to be webcast on Cortexyme’s website —
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, today announced Ch…

Research to utilize AgeX’s proprietary BAT cellular product candidate AgeX-BAT1.

Loss of non-shivering thermogenic BAT, also known as brown or good fat, in humans with aging is associated with obesity, type II diabetes, and cardiovascular disease.
…

SAN FRANCISCO–(BUSINESS WIRE)–#AI–Unlearn®, developer of the first machine-learning platform that creates Digital Twins used to enable smaller, faster clinical trials, today announced the appointment of Ann E. Taylor, M.D. to the company’s Board of …

Research to utilize AgeX’s proprietary BAT cellular product candidate AgeX-BAT1.

Loss of non-shivering thermogenic BAT, also known as brown or good fat, in humans with aging is associated with obesity, type II diabetes, and cardiovascular disease.
…